Comprehensive Analysis of Immune Cell Infiltration of m6a-Related lncRNA in Lung Squamous Cell Carcinoma and Construction of Relevant Prognostic Models

Figure 8

Validation of the model and prediction of patient survival. (a–h) This model is suitable for different clinical groups, . (i) The decision curve analysis shows that the risk is furthest from all the curves; predicting patient survival with models is superior to clinical traits. (j) Nomogram for predicting LUSC patient 1-, 3-, and 5-year overall survival.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)